208 related articles for article (PubMed ID: 27217052)
1. Thiopurine S-methyltransferase testing for averting drug toxicity: a meta-analysis of diagnostic test accuracy.
Zur RM; Roy LM; Ito S; Beyene J; Carew C; Ungar WJ
Pharmacogenomics J; 2016 Aug; 16(4):305-11. PubMed ID: 27217052
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive study of thiopurine methyltransferase genotype, phenotype, and genotype-phenotype discrepancies in Sweden.
Zimdahl Kahlin A; Helander S; Skoglund K; Söderkvist P; Mårtensson LG; Appell ML
Biochem Pharmacol; 2019 Jun; 164():263-272. PubMed ID: 31005613
[TBL] [Abstract][Full Text] [Related]
3. Thiopurine S-Methyltransferase as a Pharmacogenetic Biomarker: Significance of Testing and Review of Major Methods.
Asadov C; Aliyeva G; Mustafayeva K
Cardiovasc Hematol Agents Med Chem; 2017 Nov; 15(1):23-30. PubMed ID: 28552060
[TBL] [Abstract][Full Text] [Related]
4. Modeling the Outcome of Systematic TPMT Genotyping or Phenotyping Before Azathioprine Prescription: A Cost-Effectiveness Analysis.
Zarca K; Durand-Zaleski I; Loriot MA; Chatellier G; Pallet N
Mol Diagn Ther; 2019 Jun; 23(3):429-438. PubMed ID: 30963516
[TBL] [Abstract][Full Text] [Related]
5. Impact of NUDT15 genetics on severe thiopurine-related hematotoxicity in patients with European ancestry.
Schaeffeler E; Jaeger SU; Klumpp V; Yang JJ; Igel S; Hinze L; Stanulla M; Schwab M
Genet Med; 2019 Sep; 21(9):2145-2150. PubMed ID: 30728528
[TBL] [Abstract][Full Text] [Related]
6. Point-Counterpoint: TPMT Genotyping for Azathioprine in Adult Medicine.
Jensen CH; Fanciullo J
S D Med; 2017 Apr; 70(4):151-152. PubMed ID: 28813730
[No Abstract] [Full Text] [Related]
7. Association between thiopurine S-methyltransferase polymorphisms and thiopurine-induced adverse drug reactions in patients with inflammatory bowel disease: a meta-analysis.
Liu YP; Wu HY; Yang X; Xu HQ; Li YC; Shi DC; Huang JF; Huang Q; Fu WL
PLoS One; 2015; 10(3):e0121745. PubMed ID: 25799415
[TBL] [Abstract][Full Text] [Related]
8. Implementation of TPMT testing.
Lennard L
Br J Clin Pharmacol; 2014 Apr; 77(4):704-14. PubMed ID: 23962279
[TBL] [Abstract][Full Text] [Related]
9. Distribution of Genetic Polymorphisms of Genes Implicated in Thiopurine Drugs Metabolism.
Chadli Z; Kerkeni E; Hannachi I; Chouchene S; Ben Fredj N; Boughattas NA; Aouam K; Chaabane A
Ther Drug Monit; 2018 Oct; 40(5):655-659. PubMed ID: 30086084
[TBL] [Abstract][Full Text] [Related]
10. Association of thiopurine methyltransferase status with azathioprine side effects in Chinese patients with systemic lupus erythematosus.
Chen D; Lian F; Yuan S; Wang Y; Zhan Z; Ye Y; Qiu Q; Xu H; Liang L; Yang X
Clin Rheumatol; 2014 Apr; 33(4):499-503. PubMed ID: 24322830
[TBL] [Abstract][Full Text] [Related]
11. Establishment of thiopurine S-methyltransferase gene knockdown in jurkat T-lymphocytes: an in vitro model of TPMT polymorphism.
Misdaq M; Andag R; Oellerich M; Asif AR; von Ahsen N
Ther Drug Monit; 2012 Oct; 34(5):584-92. PubMed ID: 22972540
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of polymorphism and low activity of thiopurine methyltransferase in patients with inflammatory bowel disease.
Larussa T; Suraci E; Lentini M; Nazionale I; Gallo L; Abenavoli L; Imeneo M; Costanzo FS; Cuda G; Luzza F
Eur J Intern Med; 2012 Apr; 23(3):273-7. PubMed ID: 22385887
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetic studies of thiopurine methyltransferase genotype-phenotype concordance and effect of methotrexate on thiopurine metabolism.
Zimdahl Kahlin A; Helander S; Wennerstrand P; Vikingsson S; Mårtensson LG; Appell ML
Basic Clin Pharmacol Toxicol; 2021 Jan; 128(1):52-65. PubMed ID: 32865889
[TBL] [Abstract][Full Text] [Related]
14. Preparing Triple-Compound Heterozygous Control Material for Molecular Diagnostics of TPMT Allelic Variants.
Beránek M; Drastíková M; Bureš J; Palička V
Folia Biol (Praha); 2015; 61(3):91-6. PubMed ID: 26213853
[TBL] [Abstract][Full Text] [Related]
15. Novel thiopurine methyltransferase variant TPMT*28 results in a misdiagnosis of TPMT deficiency.
Landy J; Bhuva N; Marinaki A; Mawdsley J
Inflamm Bowel Dis; 2011 Jun; 17(6):1441-2. PubMed ID: 20945351
[No Abstract] [Full Text] [Related]
16. Development of a rapid clinical TPMT genotyping assay.
Burchard PR; Abou Tayoun AN; Lefferts JA; Lewis LD; Tsongalis GJ; Cervinski MA
Clin Biochem; 2014 Oct; 47(15):126-9. PubMed ID: 25093923
[TBL] [Abstract][Full Text] [Related]
17. Thiopurine S-methyltransferase testing for averting drug toxicity in patients receiving thiopurines: a systematic review.
Roy LM; Zur RM; Uleryk E; Carew C; Ito S; Ungar WJ
Pharmacogenomics; 2016 Apr; 17(6):633-56. PubMed ID: 27020704
[TBL] [Abstract][Full Text] [Related]
18. Reducing risk in thiopurine therapy.
Marinaki AM; Arenas-Hernandez M
Xenobiotica; 2020 Jan; 50(1):101-109. PubMed ID: 31682552
[TBL] [Abstract][Full Text] [Related]
19. Thiopurine S-methyltransferase (TPMT) assessment prior to starting thiopurine drug treatment; a pharmacogenomic test whose time has come.
Ford LT; Berg JD
J Clin Pathol; 2010 Apr; 63(4):288-95. PubMed ID: 20354201
[TBL] [Abstract][Full Text] [Related]
20. Thiopurine S-methyltransferase polymorphisms: efficient screening method for patients considering taking thiopurine drugs.
Wusk B; Kullak-Ublick GA; Rammert C; von Eckardstein A; Fried M; Rentsch KM
Eur J Clin Pharmacol; 2004 Mar; 60(1):5-10. PubMed ID: 14985890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
